NextCure, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 62.72 million compared to USD 74.73 million a year ago. Basic loss per share from continuing operations was USD 2.25 compared to USD 2.69 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +4.65% | -15.62% | +18.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.42% | 37.76M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NXTC Stock
- News NextCure, Inc.
- NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023